BACKGROUND: Inhaled nitric oxide (iNO) is an effective therapy for pulmonary hypertension and hypoxic respiratory failure in term infants. Fourteen randomized controlled trials (n = 3430 infants) have been conducted on preterm infants at risk for chronic lung disease (CLD). The study results seem contradictory. DESIGN/METHODS: Individual-patient data meta-analysis included randomized controlled trials of preterm infants (<37 weeks' gestation). Outcomes were adjusted for trial differences ...Expand abstract
- Publisher copy:
- Copyright date:
Inhaled nitric oxide in preterm infants: an individual-patient data meta-analysis of randomized trials.
Views and Downloads
If you are the owner of this record, you can report an update to it here: Report update to this record